剖宫产术后硬膜外吗啡镇痛:2-氯普鲁卡因后非劣效性随机试验
该探索性随机单盲非劣效性试验纳入40例择期剖宫产产妇,比较初始3% 2-氯普鲁卡因(CP)与2%利多卡因复合肾上腺素及碳酸氢钠(LEB)行硬膜外麻醉后,两组均于胎儿娩出后给予硬膜外吗啡3 mg。主要终点为硬膜外吗啡后24小时内总阿片类药物用量,CP组中位0(Q1=0, Q3=15.6)口服吗啡毫克当量,LEB组15(6.3-22.5),中位差-7.5(95%CI -15至0),因CI上限小于预设非劣效界值10,结论为非劣效。
要点
- 3% CP初始硬膜外麻醉后30分钟内以LEB追加,剖宫产术后硬膜外吗啡镇痛不劣于全程LEB。
- CP组24小时阿片用量中位0(Q1=0, Q3=15.6)口服吗啡毫克当量,LEB组15(6.3-22.5)。
- 两组首次请求阿片时间、疼痛评分及恶心呕吐瘙痒无显著差异。
核心结论
- 初始3% CP硬膜外麻醉后30分钟内以LEB追加,剖宫产术后硬膜外吗啡镇痛非劣效于初始及后续均用LEB。
- 既往观察到的CP后硬膜外吗啡镇痛效力下降可能源于窗口期,LEB追加或可减轻。
研究设计与样本
- 探索性、随机、单盲、非劣效性试验,纳入40例足月、择期非紧急剖宫产且已有分娩硬膜外导管的产妇,每组20例。
- 硬膜外吗啡后24小时内总阿片用量为主要终点,预设非劣效界值为10口服吗啡毫克当量。
主要发现
- CP组24小时阿片用量中位0(Q1=0, Q3=15.6)口服吗啡毫克当量,LEB组15(6.3-22.5),中位差-7.5(95%CI -15至0)。
- 非劣效成立,因95%CI上限0小于预设界值10口服吗啡毫克当量。
- 首次请求阿片时间无治疗效应,4、8、12、24小时疼痛评分及恶心呕吐瘙痒无统计学显著差异。
关键数值与推荐
- 非劣效界值预设为10口服吗啡毫克当量。
- 硬膜外吗啡剂量为3 mg,两组于胎儿娩出后给予。
- CP组初始使用3% 2-氯普鲁卡因,LEB组初始使用2%利多卡因复合1:200,000肾上腺素及碳酸氢钠。
临床怎么用
- 对已有分娩硬膜外导管的剖宫产产妇,可用3% CP快速建立麻醉,并在30分钟内以LEB追加维持,术后硬膜外吗啡3 mg镇痛。
- 该策略下24小时阿片追加量非劣效于全程LEB,可考虑用于需快速起效的剖宫产麻醉。
局限性
- 探索性研究,样本量小(共40例),需更大规模研究确认。
- 单盲设计,可能引入评估偏倚。
- 仅纳入足月、非紧急剖宫产且已有硬膜外导管的产妇,外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have suggested that administration of epidural 3% 2-chloroprocaine (CP) before epidural morphine results in decreased analgesic efficacy of epidural morphine. We sought to determine whether these observations were a result of antagonism or a window period between the conclusion of surgical anesthesia for cesarean delivery and the peak onset time of epidural morphine, and whether a method to preserve the analgesic efficacy of epidural morphine exists. METHODS: Term parturients scheduled for nonemergent, unscheduled cesarean delivery with preexisting labor epidural catheters were recruited for this exploratory, randomized, single-blinded, noninferiority trial. Subjects were randomized to initial dosing to a T4 dermatome surgical anesthetic level with either 3% CP or 2% lidocaine with 1:200,000 epinephrine and sodium bicarbonate (LEB). Subsequent redosing for both groups was performed with LEB at regular intervals. Epidural morphine 3 mg was administered to both groups after delivery. Assessing the difference between the 2 groups in total opioid use for the first 24 hours after epidural morphine administration was the primary objective. The noninferiority margin of 10 oral milligram morphine equivalents was prespecified based on previous noninferiority studies. Secondary end points included time from epidural morphine administration to first rescue opioid request, numerical pain scores, nausea/vomiting, and pruritus. RESULTS: Data were analyzed for 40 parturients, 20 in each group. The median 24-hour opioid consumption for the CP group was 0 (Q1 = 0 and Q3 = 15.6) oral milligram morphine equivalents compared to 15 (6.3-22.5) for the LEB group. The median difference was -7.5, with a 95% confidence interval -15 to 0. Noninferiority was concluded, as the confidence interval was less than the predetermined noninferiority margin of 10 oral milligram morphine equivalents. There was no treatment effect on time to first opioid request and no statistically significant differences in pain scores or nausea, vomiting, or pruritus at all time points (4, 8, 12, and 24 hours after epidural morphine administration). CONCLUSION: While designed as an exploratory study, initial epidural dosing with 3% CP and beginning subsequent redosing with LEB within 30 minutes of the initial CP bolus provided noninferior postcesarean analgesia with epidural morphine compared to initial epidural dosing and redosing with LEB. Previous observations of decreased analgesic efficacy of epidural morphine after epidural CP were likely due to a window period that may be mitigated by redosing with lidocaine; however, larger studies are necessary to confirm these findings.
引用
- Lee LO, Ramirez-Chapman AL, White DL, et al. Postcesarean Analgesia With Epidural Morphine After Epidural 2-Chloroprocaine: A Randomized Noninferiority Trial. Anesth Analg. 2022. PMID: 36534717. doi:10.1213/ANE.0000000000006109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。